Cargando…

In situ administration of cytokine combinations induces tumor regression in mice

BACKGROUND: Recent advances in cancer immunotherapy suggest a possibility of harnessing the immune system to defeat malignant tumors, but the complex immunosuppressive microenvironment confines the therapeutic benefits to a minority of patients with solid tumors. METHODS: A lentivector-based inducib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jinyu, Jiang, Haochen, Zhang, Haiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284351/ https://www.ncbi.nlm.nih.gov/pubmed/30297145 http://dx.doi.org/10.1016/j.ebiom.2018.09.050

Ejemplares similares

Administration of fusion cytokines induces tumor regression and systemic antitumor immunity
por: Zhang, Jinyu, et al.
Publicado: (2021)

Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression
por: Verma, Vivek, et al.
Publicado: (2016)

Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice
por: Chen, Meng-Chuan, et al.
Publicado: (2016)

Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression
por: Yu, Jiayun, et al.
Publicado: (2021)

In situ tumor-triggered subcellular precise delivery of multi-drugs for enhanced chemo-photothermal-starvation combination antitumor therapy
por: Jiang, Xinglu, et al.
Publicado: (2020)

Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors
por: Xia, Yiqun, et al.
Publicado: (2021)

Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression
por: Patel, Ravi, et al.
Publicado: (2018)

Administration of cytokine-induced myeloid-derived suppressor cells ameliorates renal fibrosis in diabetic mice
por: Hsieh, Ching-Chuan, et al.
Publicado: (2018)

The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models
por: Dakup, Panshak P., et al.
Publicado: (2018)

The addition of abemaciclib to sunitinib induces regression of renal cell carcinoma xenograft tumors
por: Small, Jeffrey, et al.
Publicado: (2017)

Doxorubicin modulated clock genes and cytokines in macrophages extracted from tumor-bearing mice
por: Teixeira, Alexandre Abilio S., et al.
Publicado: (2020)

Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes
por: Lim, Li Ying, et al.
Publicado: (2015)

Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression
por: zhao, Jiaojiao, et al.
Publicado: (2018)

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis
por: Aricò, Eleonora, et al.
Publicado: (2016)

Studies of Regression in a Transplantable Tumor in Mice
por: Bunting, Henry
Publicado: (1941)

Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
por: Thoreau, Maxime, et al.
Publicado: (2015)

Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients
por: Zhang, Lei, et al.
Publicado: (2017)

Protracted Hiccups Induced by Aripiprazole and Regressed after Administration of Gabapentin
por: Carbone, Manuel Glauco, et al.
Publicado: (2021)

Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression
por: Li, Wenya, et al.
Publicado: (2017)

An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor
por: Zhang, Huijuan, et al.
Publicado: (2019)

Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model
por: Su, Hongxia, et al.
Publicado: (2023)

Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling
por: Khalfaoui-Bendriss, Ghizlane, et al.
Publicado: (2015)

Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration
por: Nooh, Anas, et al.
Publicado: (2017)

An ultrastructural investigation of tumors undergoing regression mediated by immunotherapy
por: Westwood, Jennifer A., et al.
Publicado: (2017)

Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
por: Raihan, Juraimi, et al.
Publicado: (2019)

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
por: Rudqvist, Nils-Petter, et al.
Publicado: (2023)

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021)

Regression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice
por: He, Gui-Wei, et al.
Publicado: (2017)

Grey-Blue Regression in Melanoma In Situ—Evaluation on 111 Cases
por: Bassoli, S., et al.
Publicado: (2011)

PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice with Tumoral T Lymphoblasts
por: Martínez-Torres, Ana Carolina, et al.
Publicado: (2019)

Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice
por: Mirsoian, Annie, et al.
Publicado: (2014)

Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR/Cas9 induces efficient tumor regression
por: Gao, Qianqian, et al.
Publicado: (2020)

Sequential Delivery of Cyclopeptide RA-V and Doxorubicin for Combination Therapy on Resistant Tumor and In Situ Monitoring of Cytochrome c Release
por: Chen, Huachao, et al.
Publicado: (2017)

Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments
por: Fuchs, Dieter, et al.
Publicado: (2009)

Oral administration of Ginsenoside Rg1 prevents cardiac toxicity induced by doxorubicin in mice through anti-apoptosis
por: Zhu, Chen, et al.
Publicado: (2017)

Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces complete tumor regression and protective immune memory in mice
por: Skeltved, Nanna, et al.
Publicado: (2023)

Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
por: Stathopoulos, Apostolis, et al.
Publicado: (2012)

Combined administration of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in rats
por: Flora, Swaran JS, et al.
Publicado: (2008)

In-situ formed thermosensitive hydrogel amplifies statin-mediated immune checkpoint blockade for coordinated tumor chemo-immunotherapy
por: Liu, Zefan, et al.
Publicado: (2023)

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
por: Brauner, Eran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_forkk2rhift6d8l5plhmqvh9q5